Ionizing Radiation-Induced Oxidative Stress in Computed Tomography-Effect of Vitamin C on Prevention of DNA Damage: PREVIR-C Randomized Controlled Trial Study Protocol

J Clin Med. 2024 Jun 30;13(13):3866. doi: 10.3390/jcm13133866.

Abstract

Exposure to ionizing radiation (IR) is inevitable in various X-ray imaging examinations, with computed tomography (CT) being a major contributor to increased human radiation exposure. Ionizing radiation may cause structural damage to macromolecules, particularly DNA, mostly through an indirect pathway in diagnostic imaging. The indirect pathway primarily involves the generation of reactive oxygen species (ROS) due to water radiolysis induced by IR, leading to DNA damage, including double-strand breaks (DSB), which are highly cytotoxic. Antioxidants, substances that prevent oxidative damage, are proposed as potential radioprotective agents. This Study Protocol article presents the rationale for selecting vitamin C as a preventive measure against CT-associated IR-induced DNA damage, to be investigated in a randomized placebo-controlled trial, with a full in vivo design, using an oral easy-to-use schedule administration in the outpatient setting, for the single CT examination with the highest total global IR dose burden (contrast-enhanced abdomen and pelvis CT). The study also aims to explore the mediating role of oxidative stress, and it has been written in adherence to the Standard Protocol Items recommendations.

Keywords: DNA damage; antioxidants; computed tomography; ionizing radiation; oxidative stress; vitamin C.

Grants and funding

This study is sponsored by the Radiology Department of the University of Chile Clinical Hospital, the Laboratory of Oxidative Stress and Nephrotoxicity from the Molecular and Clinical Pharmacology Program (Institute of Biomedical Sciences, Faculty of Medicine; FONDECYT grant 1211850), and the Human Genetics Program (Institute of Biomedical Sciences, Faculty of Medicine, FONDECYT 11181329), all which belong to the University of Chile (contact telephone number +562-2978-2000 and address Av. Libertador Bernardo O’Higgins 1058, Santiago 8330111, Chile), a public institution, providing financial support without intervening either in the study design, execution, data interpretation or in the trial results’ communications.